about
Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S--Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationalDay-to-day variations during clinical drug monitoring of morphine, morphine-3-glucuronide and morphine-6-glucuronide serum concentrations in cancer patients. A prospective observational studyClinically significant drug-drug interactions involving opioid analgesics used for pain treatment in patients with cancer: a systematic reviewBiological pathways, candidate genes, and molecular markers associated with quality-of-life domains: an updateDeveloping quality indicators for physician-staffed emergency medical services: a consensus process.Assessment of the time-dependent need for stay in a high dependency unit (HDU) after major surgery by using data from an anesthesia information management system.Can cancer patients assess the influence of pain on functions? A randomised, controlled study of the pain interference items in the Brief Pain Inventory.Intensity and treatment of symptoms in 3,030 palliative care patients: a cross-sectional survey of the EAPC Research Network.The establishment of the GENEQOL consortium to investigate the genetic disposition of patient-reported quality-of-life outcomes.The relationship between pro-inflammatory cytokines and pain, appetite and fatigue in patients with advanced cancer.Which domains should be included in a cancer pain classification system? Analyses of longitudinal data.Health care providers underestimate symptom intensities of cancer patients: a multicenter European study.Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC.Norwegian trauma care: a national cross-sectional survey of all hospitals involved in the management of major trauma patients.Clinical and genetic factors related to cancer-induced bone pain and bone pain relief.Influences on the pharmacokinetics of oxycodone: a multicentre cross-sectional study in 439 adult cancer patients.Tromboelastography: variability and relation to conventional coagulation test in non-bleeding intensive care unit patients.Inadequate symptom control in advanced cancer patients across Europe.Do CYP2D6 genotypes reflect oxycodone requirements for cancer patients treated for cancer pain? A cross-sectional multicentre study.Long-term survival and quality of life after intensive care for patients 80 years of age or older.Innate Immune Signalling Genetics of Pain, Cognitive Dysfunction and Sickness Symptoms in Cancer Pain Patients Treated with Transdermal Fentanyl.Serum and urine concentrations of morphine and morphine metabolites in patients with advanced cancer receiving continuous intravenous morphine: an observational study.Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene.Is there a genetic cause of appetite loss?-an explorative study in 1,853 cancer patients.Genetic and Non-genetic Factors Associated With Constipation in Cancer Patients Receiving Opioids.Genetic variation and cognitive dysfunction in opioid-treated patients with cancer.Bedside dressing changes for open abdomen in the intensive care unit is safe and time and staff efficient.Genetic variation in the catechol-O-methyltransferase (COMT) gene and morphine requirements in cancer patients with painVariable response to opioid treatment: any genetic predictors within sight?Confusion with cerebral perfusion pressure in a literature review of current guidelines and survey of clinical practice.Classification of pain in cancer patients--a systematic literature review.Which variables are associated with pain intensity and treatment response in advanced cancer patients?--Implications for a future classification system for cancer pain.Biological pathways and genetic variables involved in pain.Starting step III opioids for moderate to severe pain in cancer patients: dose titration: a systematic review.Management of opioid-induced nausea and vomiting in cancer patients: systematic review and evidence-based recommendations.The importance and pitfalls of correlational science in palliative care research.Undertreatment of pain in the prehospital setting: a comparison between trauma patients and patients with chest pain.Confirming neuropathic pain in cancer patients: applying the NeuPSIG grading system in clinical practice and clinical research.Expert conference on cancer pain assessment and classification--the need for international consensus: working proposals on international standards.Risk factors and early pharmacological interventions to prevent chronic postsurgical pain following cardiac surgery.
P50
Q21203739-6C0AD9E4-2B38-4E57-9C36-A974E520A933Q24791044-0197482A-BDFF-4C55-9A83-6DC18D38B99AQ26781972-DD817B6D-C78D-41C3-B85A-4DA9BA4CA818Q28654636-8C966B2A-065B-4395-B8B3-26142A02E5D0Q30838813-3D0773B8-406D-42C4-B722-97CBBC22E794Q30959297-703E541E-3BD1-44B3-9339-9149DD589D54Q33277683-2541F653-CBCC-4CF8-A4A2-88D98B45FD1BQ33426551-89ACB658-C40A-437C-9FCA-A16E88492670Q33666335-EAD95B28-2C47-44C5-B253-D66E1ACB4F59Q33727960-AC6CD774-2F26-4E05-B33F-4117430D2058Q34134753-4F8B27DD-60FD-44F8-9747-B180C84A7FC2Q34174412-9EC5EE20-33E0-4196-93E6-28A8A1D6BBB7Q34251507-B58C1F61-EAEB-40F5-B896-119E8A344068Q34544093-6D694A2A-0E11-41B4-8939-4F7FFEF1B1A2Q34641014-C36F1F55-797D-497E-BBFB-3E62FFB89B2DQ34792547-FB8ED945-8737-4EC6-8975-DACCF93828FFQ35159344-87DE8CEE-E150-4E2A-8EF1-21CEA29C23EFQ35475449-5495D9F0-3862-4644-9E8C-AF8D3AB409FFQ35644151-329B716D-B066-4467-B6BE-BC3C41E6FFABQ35686012-80E5ECDD-825F-48E0-821D-6C232E4261FBQ35762509-AFAD82F7-6EDC-4853-963E-C2A6DA46E4E1Q35823710-833CA2A0-53E6-4684-84C1-C36133B580BBQ36016764-3565B34A-CBA5-4F2D-9A9E-E18AE91A5A45Q36179131-1D8565D2-DBCD-4053-A4E3-E9F9D53F6E58Q36751995-DB1A37E7-AB62-47B1-9D02-7BC2EC65CB36Q36893010-A469E2AF-33BE-43DB-A03F-31BAA958662EQ36945248-BB960E37-3387-495B-A9B2-8D7D8831F881Q37102220-52B6E8D0-61FF-4328-900E-6ACEE40B7FC8Q37187101-B51B4B96-104E-47EC-B150-3DF829E4B744Q37350147-EA422EEF-92D9-451A-81BE-F4082BDA5801Q37415051-7E7928DD-0D2F-4069-8EA4-73CA430DBB3BQ37786092-27A3BFB2-9144-4FB1-AA6A-38438A835D42Q37788989-1BC0D1F7-3264-4B80-9C8F-56A71AD1A2F8Q37894989-86BA7457-441E-4A19-9D09-39466BDAA2E7Q37894990-C25A1FF1-C0FA-46AD-AD12-41F59DCAA45BQ38055305-7C814878-6A20-4481-875C-7A7B7C2FB5AAQ38067581-480F8C54-5637-4F0B-8C49-AFBCE438B39CQ38166106-C135F153-74F9-4CF0-8E05-36B989352259Q38198005-DF1866B7-5E2A-4FCE-BFA8-14B0D7319109Q38220685-84CF42C7-F1C3-4514-80C9-904946A1118E
P50
description
onderzoeker
@nl
name
Pål Klepstad
@ast
Pål Klepstad
@en
Pål Klepstad
@es
Pål Klepstad
@sl
type
label
Pål Klepstad
@ast
Pål Klepstad
@en
Pål Klepstad
@es
Pål Klepstad
@sl
prefLabel
Pål Klepstad
@ast
Pål Klepstad
@en
Pål Klepstad
@es
Pål Klepstad
@sl
P1015
P1015
P106
P21
P214
179145970216732251663
P31
P569
1962-01-01T00:00:00Z
P7859
viaf-179145970216732251663